Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and cost effectiveness of Aquaphor
Healing Ointment, Atopiclair and EpiCeram as a monotherapy in mild to moderate AD.
The investigators hypothesize that no statistical difference will exist in the efficacy
between an over-the-counter moisturizer, Aquaphor Healing Ointment, compared to prescription
devices Atopiclair and EpiCeram in treating mild to moderate AD. Therefore, Aquaphor will be
most cost-effective than Atopiclair or EpiCeram.
Phase:
Phase 4
Details
Lead Sponsor:
Wake Forest School of Medicine Wake Forest University Health Sciences